What are the requirements for submitting a “Sequence Listing” in a patent application?

Question

Accepted Answer

Source: FAQ (MPEP-Based) BlueIron Update: 2024-09-30 10 Rules 5 Related FAQs This page is an FAQ based on guidance from the Manual of Patent Examining Procedure. It is provided as guidance, with links to the ground truth sources. This is information only: it is not legal advice. According to MPEP 2427 , patent applications containing nucleotide and/or amino acid sequence disclosures must include a “Sequence Listing” as a separate part of the disclosure. This can be submitted in several ways: As an ASCII text file via the USPTO’s electronic filing system On read-only optical discs As a PDF file via EFS-Web or Patent Center (not recommended) On physical sheets of paper (not recommended) The “Sequence Listing” must be in accordance with the requirements of 37 CFR 1.821-1.825. Additionally, a computer readable form (CRF) of the “Sequence Listing” is required in most cases. Related Rules from the Manual of Patent Examining Procedure 10 rules Collapse Nucleotide and Amino Acid Sequence Disclosures Not Required for Pre-July 1, 2022 Applications MPEP 2427 Sequence Listing Requirement After Form Paragraph 24.01 MPEP 2427 Required Deficiency Form Paragraphs May Follow Main Paragraph MPEP 2427 Permitted Deficiency Form Paragraphs May Follow MPEP 2427 Permitted Deficiency Form Paragraphs May Follow MPEP 2427 Permitted Deficiency Form Paragraphs May Follow MPEP 2427 Permitted Deficiency Form Paragraphs May Follow MPEP 2427 Permitted Deficiency Form Paragraphs May Follow MPEP 2427 Permitted Deficiency Form Paragraphs May Follow MPEP 2427 Permitted Deficiency Form Paragraphs May Follow MPEP 2427 Permitted Other Related FAQs 5 FAQs Collapse What are the common deficiencies in Sequence Listing submissions? What are the consequences of non-compliance with Sequence Listing requirements? How can minor errors in Sequence Listing compliance be handled? What is the incorporation-by-reference paragraph for Sequence Listings? What statements are required when submitting a Sequence Listing?